|
Avadel Pharmaceuticals Plc (AVDL) |
|
Avadel Pharmaceuticals Plc
AVDL's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Avadel Pharmaceuticals Plc growth rates, revenue grew
in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 181
Major Pharmaceutical Preparations industry recorded
growth of revenues by 5.17 %
Avadel Pharmaceuticals Plc net loss decreased from $-31 millions, to $-14 millions in II. Quarter 2024,
• More on AVDL's Growth
|
|
Avadel Pharmaceuticals Plc realized a net loss in trailing twelve months.
Avadel Pharmaceuticals Plc realized cash reduction of $ -0.35 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 16.69.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.75.
• More on AVDL's Valuation
|
|
|
|
|
Avadel Pharmaceuticals Plc realized net loss in trailing twelve months.
Avadel Pharmaceuticals Plc realized cash outflow of $ -0.35per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 16.69.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.75.
Avadel Pharmaceuticals Plc Price to Book Ratio is at 18.02 lower than Industry Avg. of 84.78. and higher than S&P 500 Avg. of 0
• More on AVDL's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com